Our study here elucidated, at least in part, the mechanism by which some types of cancer, including breast cancer, adjust elevated SLC7A11 levels to meet a high requirement of cystine consumption, and subsequent cysteine-depleted microenvironment to ensure their survival (51). This evidence concerns the gene SLC7A11 and breast cancer.